Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:58:00 EDT Wed 09 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:TECH - BIO-TECHNE CORP - http://www.rndsystems.com/cyt_cat/profile.html
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TECH - Q0.272.15·72.272.372.25-0.06-0.11,987.2142,47612,64772.30  72.365  72.2372.62  43.19517:18:07Sep 0115 min RT 2¢

Recent Trades - Last 10 of 12647
Time ETExPriceChangeVolume
17:18:07Q72.25-0.0611,906
16:25:16Q72.1709-0.13911
16:20:00Q72.25-0.066
16:15:00Q72.25-0.061
16:15:00Q72.25-0.061
16:10:05Q72.25-0.061
16:10:05Q72.25-0.061
16:10:05Q72.25-0.061
16:10:05Q72.25-0.061
16:10:05Q72.25-0.061

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-01 06:30U:TECHNews ReleaseBio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
2026-08-13 06:30U:TECHNews ReleaseBio-Techne Corrects Dividend Announcement
2026-08-12 06:30U:TECHNews ReleaseBio-Techne Releases Fourth Quarter Fiscal 2026 Results
2026-08-12 06:30U:TECHNews ReleaseBio-Techne Declares Dividend
2026-07-08 06:30U:TECHNews ReleaseBio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
2026-06-25 06:10U:TECHNews ReleaseMerck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
2026-06-04 06:30U:TECHNews ReleaseBio-Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
2026-05-06 06:30U:TECHNews ReleaseBio-Techne Releases Third Quarter Fiscal 2026 Results
2026-05-06 06:30U:TECHNews ReleaseBio-Techne Declares Dividend
2026-05-04 07:00U:TECHNews ReleaseBio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
2026-04-16 08:00U:TECHNews ReleaseBio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
2026-04-14 07:00U:TECHNews ReleaseBio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
2026-03-25 06:30U:TECHNews ReleaseBio-Techne Advances Spatial Biology with Modular Expansion of COMET(TM) Suite
2026-02-24 07:00U:TECHNews ReleaseBio-Techne to Present at Upcoming Investor Conferences
2026-02-16 06:30U:TECHNews ReleaseBio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories
2026-02-11 09:00U:TECHNews ReleaseBio-Techne Announces Changes to its Leadership Team
2026-02-04 06:30U:TECHNews ReleaseBio-Techne Releases Second Quarter Fiscal 2026 Results
2026-02-04 06:30U:TECHNews ReleaseBio-Techne Declares Dividend
2026-02-02 06:30U:TECHNews ReleaseBio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
2026-01-28 06:30U:TECHNews ReleaseBio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers